#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neovascular age-related macular degeneration NTRK gene fusion overexpression Hyperphagia Pyoderma gangrenosum Focal segmental glomerulosclerosis Small intestine leiomyosarcoma Complex regional pain syndrome Breast cancer Castleman's disease Chronic graft versus host disease Splenic marginal zone lymphoma Medulloblastoma recurrent Arrhythmogenic right ventricular dysplasia Chronic myeloid leukaemia (in remission) Hypoxic-ischaemic encephalopathy More trials…

    Learn about Rare Diseases

    Mucous membrane pemphigoid Ewing’s sarcoma recurrent – Life with Disease Burkitt’s lymphoma Primary immunodeficiency syndrome – Basic Information Idiopathic inflammatory myopathy – Treatment Lysosomal storage disorder – Trials in Disease Waldenstrom’s macroglobulinaemia refractory – Trials in Disease Osteosarcoma metastatic Testicular leiomyosarcoma – Diagnostics Propionic acidaemia – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Parsaclisib Hydrochloride Losartan Clofarabine Efepoetin Alfa Glucose Asparaginase Losartan Potassium Mosunetuzumab SAR443820 AMLENETUG Eribulin Mesylate Edg-5506 Odm-212 Bp1.7881A Lansoprazole Lovotibeglogene Autotemcel LIGUFALIMAB Ranolazine R-Azasetron Besilate HAFNIUM OXIDE More therapies…

    Learn about Your Condition

    Postpartum haemorrhage Breast cancer stage I Frontotemporal dementia Eosinophilic gastritis Tendon disorder Pharyngeal cancer stage II Vaginal haemorrhage Small cell carcinoma Appendicitis perforated Skin angiosarcoma Diarrhoea Cutibacterium acnes infection Post-acute COVID-19 syndrome Acromegaly Cervix carcinoma stage I More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Indywidualna Specjalistyczna Praktyka Lekarska

Indywidualna Specjalistyczna Praktyka Lekarska

Al. Powstańców Wielkopolskich 66/68, Szczecin, 70-111, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Salbutamol
    • Glycopyrronium Bromide
    • Budesonide
    Austria Bulgaria Czechia Denmark Finland France +10

  • Study on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma Not Well Controlled

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Salbutamol
    • Formoterol Fumarate
    • Glycopyrronium Bromide
    Bulgaria Hungary Italy Poland Romania Spain

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!